Geneos Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$842K Sell
1,892
-3,021
-61% -$1.34M 0.02% 580
2025
Q1
$2.38M Buy
4,913
+3,460
+238% +$1.68M 0.03% 446
2024
Q4
$585K Sell
1,453
-244
-14% -$98.3K 0.02% 548
2024
Q3
$789K Buy
1,697
+1,623
+2,193% +$755K 0.03% 453
2024
Q2
$34.7K Buy
74
+5
+7% +$2.34K ﹤0.01% 1195
2024
Q1
$28.8K Sell
69
-15
-18% -$6.27K ﹤0.01% 1255
2023
Q4
$34.2K Sell
84
-107
-56% -$43.5K ﹤0.01% 1188
2023
Q3
$66.4K Buy
191
+54
+39% +$18.8K ﹤0.01% 992
2023
Q2
$48.2K Buy
137
+130
+1,857% +$45.7K ﹤0.01% 1087
2023
Q1
$2.21K Sell
7
-120
-94% -$37.8K ﹤0.01% 1887
2022
Q4
$36.7K Hold
127
﹤0.01% 1157
2022
Q3
$36K Sell
127
-318
-71% -$90.1K ﹤0.01% 1136
2022
Q2
$127K Hold
445
0.01% 918
2022
Q1
$116K Buy
445
+120
+37% +$31.3K 0.01% 1026
2021
Q4
$71K Buy
325
+100
+44% +$21.8K ﹤0.01% 1319
2021
Q3
$40K Buy
225
+1
+0.4% +$178 ﹤0.01% 1599
2021
Q2
$44K Sell
224
-2,380
-91% -$468K ﹤0.01% 1545
2021
Q1
$568K Sell
2,604
-354
-12% -$77.2K 0.02% 607
2020
Q4
$605K Buy
2,958
+2,350
+387% +$481K 0.02% 483
2020
Q3
$163K Sell
608
-300
-33% -$80.4K 0.01% 757
2020
Q2
$259K Buy
908
+270
+42% +$77K 0.01% 588
2020
Q1
$138K Buy
638
+100
+19% +$21.6K 0.01% 737
2019
Q4
$118K Hold
538
0.01% 888
2019
Q3
$89K Buy
538
+14
+3% +$2.32K 0.01% 940
2019
Q2
$96K Sell
524
-50
-9% -$9.16K 0.01% 926
2019
Q1
$105K Sell
574
-24
-4% -$4.39K 0.01% 850
2018
Q4
$96K Hold
598
0.01% 851
2018
Q3
$115K Buy
598
+29
+5% +$5.58K 0.01% 841
2018
Q2
$96K Sell
569
-70
-11% -$11.8K 0.01% 802
2018
Q1
$104K Hold
639
0.01% 741
2017
Q4
$95K Sell
639
-67
-9% -$9.96K 0.01% 763
2017
Q3
$107K Buy
706
+453
+179% +$68.7K 0.01% 679
2017
Q2
$32K Hold
253
﹤0.01% 1103
2017
Q1
$27K Sell
253
-22
-8% -$2.35K ﹤0.01% 1135
2016
Q4
$20K Hold
275
﹤0.01% 1190
2016
Q3
$23K Buy
275
+22
+9% +$1.84K ﹤0.01% 1091
2016
Q2
$22K Hold
253
﹤0.01% 1093
2016
Q1
$20K Buy
+253
New +$20K ﹤0.01% 1095